New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
Black
C
C
Department of Clinical Pharmacology, Royal Infirmary, Glasgow G4 OSF.
Paterson
K R
KR
D001241:Aspirin / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects; D000077144:Clopidogrel; D006801:Humans; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy*; D013988:Ticlopidine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin